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ABSTRACT:
The ALK (Anaplastic Lymphoma Kinase) gene encodes a tyrosine kinase receptor 
preferentially expressed in the central and peripheral nervous systems. A syndromic 
presentation associating congenital neuroblastoma with severe encephalopathy 
and an abnormal shape of the brainstem has been described in patients harbouring 
de novo germline F1174V and F1245V ALK mutations. Here, we investigated the 
phenotype of knock-in (KI) mice bearing the AlkF1178L mutation (F1174L in human). 
Although heterozygous KI mice did not reproduce the severe breathing and feeding 
difficulties observed in human patients, behavioral tests documented a reduced 
activity during dark phases and an increased anxiety of mutated mice. Matings of 
heterozygotes yielded the expected proportions of wild-type, heterozygotes and 
homozygotes at birth but a high neonatal lethality was noticed for homozygotes. 
We documented Alk expression in several motor nuclei of the brainstem involved in 
the control of sucking and swallowing. Evaluation of basic physiological functions 12 
hours after birth revealed slightly more apneas but a dramatic reduced milk intake 
for homozygotes compared to control littermates. Overall, our data demonstrate that 
Alk activation above a critical threshold is not compatible with survival in mice, in 
agreement with the extremely severe phenotype of patients carrying aggressive de 
novo ALK germline mutations.
INTRODUCTION
The ALK (Anaplastic Lymphoma Kinase) gene 
encodes a tyrosine kinase receptor that belongs to the 
insulin-receptor superfamily [1,2]. It is involved in 
many human cancers through a variety of mechanisms, 
including translocations, amplifications and activating 
point mutations [3,4]. In neuroblastoma, a pediatric cancer 
of the peripheral sympathetic nervous system (SNS), 
such mutations have been identified in both familial 
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and sporadic cases with different spectra: whereas three 
hotspots of mutations have been described in sporadic 
cases, at positions F1245, R1275 and F1174, no germline 
mutation affecting the F1245 and F1174 residues has been 
reported in neuroblastoma families [5,6]. The R1275Q 
is the most frequent germline mutation observed in 
these forms [7,8]. The observation of missing germline 
mutations relative to the somatic repertoire suggested 
that a highest activity of these mutated forms may induce 
severe effects during embryonic development resulting 
in embryonal lethality. Yet, a syndromic presentation 
associating congenital neuroblastoma with severe 
encephalopathy and abnormal shape of the brainstem has 
now been described in two sporadic cases harbouring de 
novo germline F1174V and F1245V ALK mutations [9]. 
These patients presented with major feeding difficulties, 
associated with poor sucking and swallowing. They 
exhibited breathing difficulties with severe apneas and 
respiratory support was provided in both cases. They were 
also hypotonic and died before one year of age.
The involvement of the ALK gene in neuroblastoma 
and neurological disorders is indeed consistent with 
its preferential expression in the central and peripheral 
nervous systems that has been reported in mammals 
[10–12]. However, the precise function of full length 
ALK remains poorly understood. The in vivo function of 
ALK has been largely evaluated in the model organism 
Drosophila melanogaster. Drosophila embryos lacking 
dALK die due to abnormalities in the formation of gut 
musculature [13] and the dALK receptor is also involved 
in the neuronal circuit assembly of the visual system 
[14]. More recently, it has been shown that dALK plays 
critical roles in body size determination and associative 
olfactory learning [15] and that it permits central nervous 
system (CNS) growth under nutrient restriction [16]. In 
contrast to Drosophila, mice deficient in Alk are viable, 
fertile and display a normal appearance [17,18]. However, 
some abnormalities in behavioral tests have been reported. 
Analysis of another mouse strain inactivated for Alk 
revealed that mutant mice consumed more ethanol than 
wild-type (WT) mice and showed resistance to the ataxic 
effect of ethanol [19]. We recently described a prolonged 
neurogenesis in the SNS of knock-in (KI) mice bearing 
Alk R1279Q and F1178L activating mutations as well as 
a strong cooperation between Alk mutations and MYCN 
overexpression in neuroblastoma formation [34]. The 
studied mutations correspond to the ALK R1275Q and 
F1174L mutations observed in neuroblastoma patients, 
respectively.
In the present paper, we sought to determine 
whether KI AlkF1178L mice phenocopy the severe 
neurological disorders observed in patients with de novo 
germline activating ALK mutations [9]. We analyzed in-
depth basic physiological functions of heterozygous and/
or homozygous KI AlkF1178L animals, including behavior, 
breathing and feeding. We also investigated Alk expression 
in the brainstem, which is crucial for many basic 
functions and performed a complete histology analysis 
of homozygotes at birth. Altogether, our data strongly 
suggest that Alk activation above a critical threshold 
impairs survival in mice.
RESULTS
Heterozygous KI AlkF1178L mice are viable and 
display few behavioral abnormalities
Heterozygous (HT) KI AlkF1178L HT mice were 
generated at Institut Clinique de la Souris (Illkirch-
Graffenstaden, France). Two animals were used to expand 
the line and consecutive backcrosses with C57Bl6/N 
WT animals were performed for at least 6 generations. 
Alk cDNA obtained from brain of HT mice showed 
equivalent expression of both alleles (data not shown). 
These HT animals had a normal physical appearence and 
were indistinguishable from WT littermates. Taking into 
account all backcrosses we obtained at weaning 46 % 
of HT (429 HT/928 animals). This is slightly below the 
expected ratio of 50% (chi-square test, p = 0.02). 
Abnormalities in behavioral tests have been noticed 
in Alk deficient mice [17]. We therefore submitted 
HT KI AlkF1178L and WT male mice to a battery of tests 
including: (1) circadian activity and ingestive behaviors 
as well as modified SHIRPA for general health and gross 
neurological examination; (2) rotarod and grip tests for 
motor abilities and muscle strength; (3) slit lamp and 
topical endoscopy fundus imaging for analysis of the 
visual system; (4) hot plate test for pain sensitivity; 
(5) light/dark test for anxiety-related behavior; (6) tail 
suspension test for depression-like behavior; (7) auditory 
startle reflex reactivity and pre-pulse inhibition test for 
sensorimotor gating; (8) Y-maze test and pavlovian fear 
conditioning tests for learning and memory and (9) blood 
analysis. HT mice had good general health and did not 
show any obvious sign of altered sensory or vestibular 
function. However, we could detect significant differences 
compared to WT in a subset of tests. For the circadian 
activity, HT were less active during the dark phases for 
both locomotor activity and rears (Figure 1A). HT mice 
showed significantly increased muscle strength when 
animals were allowed to grip with all paws (WT: 7.24 ± 
0.17 g per gram; HT: 7.93 ± 0.23 g per gram; p<0.05). 
Minor abnormalities of the visual system, i. e. presence of 
a small zone of higher reflectance under one of the main 
blood vessels and/or a small white spot under a vein, were 
observed in 7 out of the 11 HT mice. During the dark/light 
test, HT spent less time in the light side, waited longer 
before going for the first time in the light side and did 
less light/dark transitions (Figure 1B). Blood analysis 
showed that HT mice displayed slightly higher alkaline 
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phosphatase and chloride concentrations compared to WT 
littermates (Figure 1C). HT did not show any difference 
with WT in the other tests, in particular in the Y-maze 
and tail suspension tests (Supplementary figure 1A-1B, 
respectively). Altogether, these observations indicate 
that mice bearing the AlkF1178L activating mutation at the 
heterozygous status displayed an increased anxiety in the 
dark/light test but no severe neurological alterations.
High neonatal lethality of homozygous KI AlkF1178L 
mice
We hypothetized that mice may be more resistant to 
ALK activation than humans. With the aim to potentially 
increase the phenotype induced by activated Alk, matings 
between HT were performed to obtain homozygous (HM) 
KI AlkF1178L mice. At birth, a quarter of all genotyped 
animals were HM (Figure 2A) and these animals could 
not be distinguished from WT and HT (Figure 2B, 
upper panel). This demonstrates that this mutation was 
not embryonic lethal in mice even when homozygous. 
However, at weaning HM animals represented only 3.8 
% of all animals (Figure 2A). Therefore a homozygous 
AlkF1178L mutation induces a strong neonatal lethality. 
Analysis of the precise day of death showed a major peak 
of lethality between 24 hours (P1) and 48 hours (P2) after 
birth (Figure 2C). In addition, we noticed that the subset of 
HM that survived more than two days were smaller, lighter 
than WT and presented with a delay in skin pigmentation 
Figure 1: Behavioral abnormalities of heterozygous adult KI AlkF1178L males. A. Monitoring of locomotor activity and rears 
during dark and light phases. Each dot represents the mean of animals on one hour periods. The difference between genotypes was 
significant during the first dark phase for locomotor activity (p<0.05) and the number of rears was also significantly decreased in HT males 
during the dark phases (p<0.05). B. Results of the light/dark test indicate an increased anxiety of HT mice. C. Concentration of alkaline 
phosphatase and chloride in HT and WT mice. Error bars correspond to SEM, p-value for t-test *: <0.05, **: <0.01, ***: <0.001.
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and fur growth (Figure 2B, middle and lower panels and 
figure 2D). In order to investigate whether this growth 
delay was associated with a delay in bone maturation, we 
performed whole-body X-rays of one HM and one WT 
at 6 weeks of age. The HM showed shorter femoral and 
tibial diaphyses, in accordance with the smaller size of 
the HM population described above (Figure 2E). Still, 
observation of ossification of epiphyseal cartilages at 
inferior extremity of femur and superior extremity of tibia 
showed no maturation delay in the HM.
At birth, homozygous KI AlkF1178L mice do not 
present abnormalities in brainstem and whole-
body histology
The syndromic patients with de novo germline 
activating ALK mutations presented with an enlarged 
medulla obloganta evidenced by magnetic resonance 
imaging [9]. We therefore sought to document Alk 
expression in the brainstem and determine whether KI 
AlkF1178L mice exhibited abnormalities of this structure. In 
Figure 2: High neonatal lethality of homozygous KI AlkF1178L mice and growth delay of surviving homozygotes. A. 
Breedings between HT were performed to obtain HM. Results of genotyping at birth (n=502) and at weaning (n=158) are shown. At 
birth: WT: n=131, HT: n=248 and HM: n=123. At weaning: WT: n=55, HT: n=97 and HM: n=6. p-value for the chi-square test: 7.10-8 B. 
Representative pictures of litters at different ages. At birth, the 3 genotypes are indistinguishable (WT, n=2; HT, n=2; HM, n=3). At P3, the 
subset of HM that survive may be identified due to their reduced size and delay in skin pigmentation. At P25, the surviving HM still present 
with a reduced size. C. Survival curves indicating the time of death for HM. D. Mean weight of each genotype from birth to weaning. Error 
bars correspond to SEM. E. X-ray of back paw of one WT and one HM young adults. Epiphyseal plates are indicated by arrows and present 
in both animals. White bar: 1 cm.
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situ hybridization (ISH) of Alk was performed on fixed 
brainstems of WT mice at different stages from E15.5 to 
P0. Alk expression was consistently detected in the inferior 
olivary nucleus as well as in different cranial nerve motor 
nuclei including the hypoglossal (XIIn), ambiguus, facial 
(VIIn) and trigeminal (Vn) nuclei (Figure 3 and data 
not shown). These nuclei are involved in the control of 
sucking and swallowing. The same pattern of expression 
was observed in the HM embryos at E18.5 (Figure 3). We 
confirmed by Western blot that the mutated Alk protein 
was indeed expressed in the brainstem of HM mice at 
similar level compared to WT littermates (Supplementary 
figure 2). Our ISH experiments also revealed that the 
motor nuclei expressing Alk were present in HM mice 
with non altered shape and size compared with control 
littermates.
In order to find what could be responsible for HM 
death, we performed a whole-body histology analysis with 
HES (Hematoxylin-Eosin-Safran) staining on 5 HM and 
5 WT at birth (Supplementary figure 3A). This analysis 
showed that all organs were normal in terms of size, shape 
and cellular aspect. A specific examination of the adrenal 
gland did not reveal any abnormality in the HM mice.
Minor breathing abnormalities but dramatic 
decreased milk intake of homozygous KI AlkF1178L 
mice at birth
Major breathing and feeding difficulties 
characterized the children with de novo germline activating 
ALK mutations and these patients required respiratory 
support and tube feeding [9]. We were therefore interested 
in the capacity of HM KI AlkF1178L mice to breath and 
feed normally. First, we investigated breathing of the HM 
mice to determine whether they showed defects, such 
as many apneas similarly to the patients. We analyzed 
94 pups around 12 hours after birth using whole-body 
plethysmography, in three different conditions including 
normoxia, hypercapnia and hypoxia. No differences were 
Figure 3: Absence of abnormalities of the brainstem nuclei expressing Alk in HM KI AlkF1178L mice. A. In situ hybridization 
on coronal sections (rostral to caudal) of brainstem of WT and HM embryos at E18.5 with an Alk probe. Black scale bar: 0.5 mm. B. 
Magnification images of the cranial nerve motor nuclei. IO: Inferior Olivary nucleus; XIIn: hypoglossal motor nucleus; VIIn: facial motor 
nucleus; Vn: trigeminal motor nucleus. 
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detected in the plethysmography measurements, i.e. tidal 
volume (VT), breath duration (TTOT), and minute ventilation 
(VE, calculated as VT/TTOT) (Supplementary figure 4A-
4C) showing that HM breathed correctly with the same 
rate and volume compared to controls. We documented 
that HM responded correctly to hypercapnia and hypoxia 
(Figure 4A and Supplementary figure 4A-4C). However, 
we noticed that HM spent about 30% more time in apneas 
in normoxia condition (Figure 4B). Movements were 
also recorded during the three conditions. In particular, 
activity duration is indicative of the arousal and defensive 
response to hypercapnia. We observed that this movement 
response to hypercapnia was markedly disrupted in HM 
and HT mice compared to WT mice (Supplementary figure 
4D). In contrast, no difference was recorded between the 
three genotypes neither in hypoxia nor in normoxia. 
The measurement of body weight on these 94 
animals (WT, HT, HM) showed that there was no 
difference according to the genotype at birth. It was 
confirmed on a larger series of 236 pups (Figure 2D). 
The interscapular skin temperature of the 94 pups was 
recorded when the mother just went outside the nest. This 
measurement did not show any difference that could have 
suggested that HM mice were excluded from nest (data not 
shown). On the same cohort of 94 pups, the heart rate was 
similar for the three genotypes (data not shown).
To investigate the feeding capacity of the newborn 
mice, the stomach of animals born from HT intercrosses 
was scored at birth into 4 levels: empty, traces, full or 
distended (Figure 4C). This analysis showed that whereas 
about a quarter of WT presented with a distended stomach 
only one HM out of 46 was classified in this category 
Figure 4: Analysis of basic physiological functions at birth reveals a strong decreased milk intake for homozygous KI 
AlkF1178L mice. A. Apneas were recorded by whole-body plethysmography on 94 newborn mice (WT, n=27; HT, n=41; HM, n=26) under 
normoxia, hypercapnia and hypoxia. Means of apnea duration for all genotypes are shown in the different conditions. Each dot represents 
a period of 30 seconds. Error bars correspond to SEM. B. Normalized apneas duration during normoxia are shown. Each apneas duration 
for the 10 min of normoxia was normalized by the mean of the duration in the litter. p-value for t-test between WT and HM = 0.00055. C. 
Representative pictures of milk intake in the stomach of newborn mice scored as traces (left panel), full (middle panel) or distended (right 
panel). D. Repartition of different milk intake scores for each genotype (WT, n= 62; HT, n=103; HM, n=46), p-values for the chi-square 
tests ***: <0.001.
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(Figure 4D). Moreover the proportion of animals having at 
least a full stomach was 61% for WT, 48% for HT but only 
13% for HM. In conclusion, this analysis demonstrates 
that HM did slightly more apneas than littermate controls 
but this difference may hardly account for the neonatal 
lethality. Nevertheless, the HM exhibited a dramatic 
reduced milk intake consistent with the phenotype 
observed in patients.
DISCUSSION
In the present paper, we performed an in-depth 
phenotyping analysis of KI AlkF1178L mice. In particular, 
we sought to determine whether these mice reproduce the 
severe neurological disorders observed in patients with de 
novo heterozygous germline activating ALK mutations. 
Our data clearly indicate that mice exhibiting one mutated 
Alk F1178L allele did not display severe abnormalities 
related to those observed in the patient bearing an ALK 
F1174V mutation. This difference is unlikely due to the 
difference in the amino acid variation. The F1178 residue 
in the murine receptor corresponds to the F1174 position 
in the human receptor and the kinase domains of both 
receptors exhibit only four differences. The F1174 residue 
lies in the alpha C helix [3] and it has been suggested that 
a F to L change will result in an increased affinity for 
ATP [20]. The F1174L mutation has been shown to be a 
ligand-independent activating mutation [21]. The L and V 
residues present with the same physicochemical properties 
and are expected to induce the same consequences on the 
receptor’s activity.
We recorded few abnormalities of heterozygous 
KI AlkF1178L mice in behavioral tests, including a reduced 
activity during dark phases and an increased anxiety in the 
dark/light test compared to control littermates. However, 
we did not notice any abnormalities either in the learning 
and memory function, or in the susceptibility to despair. A 
few anomalies have also been reported in homozygous KO 
Alk mice [17] and double homozygous KO Alk/Ltk mice 
[18]. In the first study, authors reported an antidepressant 
profile, i.e. a decreased susceptibility to despair of KO 
Alk mice. No effect of Alk inhibition was detected on the 
locomotor activity and the anxiety. Results of the second 
study, suggested a decreased anxiety for Alk mutants and 
an increased performance in spatial memory. Interestingly, 
this phenotype is consistent with the one described in 
Drosophila, since dAlk inhibition was shown to enhance 
olfactory associative learning in this model organism [15]. 
It therefore appears that whereas Alk inhibition decreases 
anxiety in mice, Alk activation induces an opposite effect. 
We could not demonstrate effects of Alk activation on 
cognitive functions in our model. However, behavioral 
tests were performed only on HT KI AlkF1178L mice and 
not on HM mice, due to the small number of surviving 
HM animals.
Although the HT mice did not exhibit strong 
phenotypes, we documented a high neonatal lethality of 
HM KI AlkF1178L mice. We excluded an embryonic lethality 
since the expected proportions of the various genotypes 
were observed at birth from heterozygotes intercrosses. 
The newborn mutants could not be distinguished from 
the control littermates, indicating that Alk activation did 
not induce effects during in utero development that would 
be macroscopically visible at birth. We also obtained 
and characterized another KI Alk mouse line bearing 
a R1279Q mutation (corresponding to the R1275Q 
mutation in neuroblastoma patients). We did not observe 
any difference in the apparent phenotype and survival of 
R1279Q HT and HM animals compared to WT littermates. 
Breedings of HT provided the expected proportions of the 
different genotypes at weaning (n=26 WT, n=57 HT and 
n=26 HM, corresponding to 24%, 52% and 24% of all 
animals, respectively). This demonstrates that, in contrast 
to the F1178L mutation, the R1279Q mutation did not 
induce a neonatal lethality in mice. These differences 
between both Alk mutations highly suggest a threshold 
of Alk activation compatible with survival. We recently 
bred KI AlkF1178L mice with mice expressing a truncated 
Alk receptor without a functional kinase domain. We 
therefore got hemizygote animals in which only one 
mutated Alk F1178L allele is expressed, in the absence 
of WT Alk. These animals did not show post-natal 
lethality (data not shown). This indicates that the absolute 
level of activated Alk, rather than a balanced expression 
between the mutant and WT forms is critical for survival. 
Furthermore the highest impact of the F1178L mutation 
on mice survival is consistent with the higher oncogenic 
potential of the F1178L mutation compared to the R1279Q 
mutation that we recently demonstrated in vivo [34]. Of 
interest, mutation at position 1245 in the human syndrome 
associating neuroblastoma and severe encephalopathy 
corresponds to the third hotspot of mutation reported 
exclusively at the somatic level in sporadic neuroblastoma 
and not described at the germline level in neuroblastoma 
families. One can predict that such a mutation would also 
impair survival in mice. Finally, neither developmental 
abnormalities nor neurological disorders have been 
reported in patients with ALK germline activating 
mutations observed in a context of familial neuroblastoma, 
suggesting that these mutations are indeed less aggressive.
Since the children presenting with de novo germline 
F1174V and F1245V activating ALK mutations displayed 
abnormal shape of the brainstem, we investigated this 
structure in KI AlkF1178L mice. We documented high 
expression of Alk mRNA in brainstem motor nuclei 
involved in control of sucking and swallowing. However 
no differences in size and shape of these nuclei could be 
evidenced between mutant and WT mice. We performed 
as well a global histology analysis of newborn mice that 
did not reveal any overt abnormalities. Only a focused 
analysis of the SNS ganglia indicated an enlargement of 
the superior cervical and stellate ganglia in Alk R1279Q 
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and F1178L knock-in mice [34]. Therefore it appears 
that Alk activation does not induce morphological 
abnormalities of the brainstem or vital organs that could 
account for the neonatal lethality of HM mice exhibiting 
the F1178 mutation. 
With respect to the breathing function, KI AlkF1178L 
mutant newborns were never seen cyanosed and only 
exhibited a modest increase in apneas duration compared 
to WT mice. These modest abnormalities are unlikely 
to explain the cause of HM animals death. This results 
strongly contrasts with the dramatic phenotype associated 
with determined mutations of Phox2b, which regulates Alk 
expression [22] and is also associated with neuroblastoma 
[5,23]. Specifically, Phox2b KI mice with polyalanine 
expansion died very soon after birth from major breathing 
difficulties and huge apneas [24]. 
Whereas breathing was not strongly affected in 
mutant newborns, we documented that feeding was 
severely impaired in KI AlkF1178L HM. This observation 
may be closely related to the feeding difficulties that 
characterized the patients. In mice, it remains to be 
determined whether the reduced milk intake of mutant 
newborns results from specific sucking or swallowing 
defects or may be linked to a difficult access to the udder in 
the litter. It is of interest to mention that we never observed 
milk in the lungs of the HM newborns that were subjected 
to whole-body histology analysis, which suggests that 
these animals did not swallow the wrong way. Although 
we did not observe morphological anomalies of the 
brainstem nuclei expressing Alk and controlling sucking 
and swallowing we cannot exclude that Alk activation may 
functionally affect a subset of these neurons leading to a 
deficient milk intake. Another hypothesis would be that 
the feeding difficulties may not be related to the brainstem 
functions but to other CNS structures expressing the Alk 
receptor and playing a role in feeding and/or appetite 
regulation. Indeed, data of the literature and from our 
analysis indicate that Alk expression in mouse brain is 
not restricted to the brainstem [10-12]. In particular, it 
is expressed in the olfactory bulb. Impaired olfactory 
neurogenesis may induce olfactory deficits that could 
affect feeding of newborns. However, we did not observe 
any overt difference in HES of the olfactory bulb between 
WT and HM (Supplementary figure 3B), which is not in 
favour of such an hypothesis.
Overall, our data shed light on the activity-
dependent and crucial role of Alk in the control of 
essential physiological functions in mice, in agreement 
with the extremely severe neurological disorders observed 
in patients carrying the most aggressive ALK germline 
mutations.
METHODS
Mouse line construction and genotyping 
The construction of the mouse KI AlkF1178L line as 
well as genotyping conditions are described elsewhere [34]. 
Briefly, the KI AlkF1178L allele differs from the WT allele 
by an insertion of 75 pb in the 22nd intron including a loxP 
site, a substitution TTC>CTC in the codon for the F1178 
amino acid and another insertion of 75 pb in the 23rd intron 
including a lox511 site. The genotyping primers Lf4735 
(5’ GTCGGCAGGAGATTTCAGAGACCA 3’) and 
Mr4736 (5’ GCAGGAGTTGAATTAGCGGGAAAAG 
3’) are flanking the first insertion. It allows to discriminate 
the WT allele (374 bp) and the KI AlkF1178L allele (449 bp).
The care and use of animals further used in this study 
was strictly applying European and National Regulation 
in force for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes (Directive 
86/609).
Phenotypic analysis of adult KI AlkF1178L males
This analysis was performed by Institut Clinique 
de la Souris (Illkirch-Graffenstaden, France). Twelve 
WT and 11 KI AlkF1178L HT male mice were used for this 
study. They were allowed at least one week acclimation 
in phenotyping area with controlled temperature (21-
22°C) under a 12-12 light-dark cycle, with food and 
water available ad libitum. Testing started at 11-12 week-
old and was carried out in accordance with European 
institutional guidelines. Modified SHIRPA [25], rotarod, 
grip, hot plate and tail suspension tests, auditory startle 
reflex reactivity and prepulse inhibition test, Y-maze 
spontaneous alternation task [26,27] and Pavlovian fear 
conditioning [28] were performed as previously described. 
Briefly, for circadian activity and ingestive behaviors, 
spontaneous locomotor activity and rears were measured 
using 24 individual boxes equipped with infra-red captors. 
The quantity of water and food consumed was measured 
during the test period using automated pellet feeder 
and lickometer (Imetronic, Pessac, France). Mice were 
tested for 32 hours in order to measure habituation to the 
apparatus as well as nocturnal and diurnal activities. For 
visual clinical observations, the anterior segment (cornea, 
pupil, lens) of the eye was examined on vigil mice with 
a slit lamp (model 990 5X;CSO, Luneau, France) before 
and after pupil dilatation with a drop of 0.5% tropicamide 
(Novartis). The posterior segment (retina) was observed 
through topical endoscopy fundus imaging [29]. For blood 
analysis, blood was collected at 9.00 am on non fasted 
mice by retro orbital puncture under isoflurane anaesthesia. 
Blood chemistry was performed on an OLYMPUS 
AU-400 automated laboratory work station (Olympus 
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France SA, Rungis, France) using commercial reagent 
(Olympus Diagnostica GmbH, Lismeehan, Ireland). A 
complete blood count was performed on an Advia 120 
Vet (Siemens). Plasma immunoglobulins (IgG subclasses, 
IgA, IgM and IgE) were measured by immunoanalysis 
according to the Europhenome procedures (http://www.
europhenome.org/). More detailed protocols are available 
on request. All data are expressed as mean ± SEM. 
Comparisons between HT and WT mice were performed 
using a Student t test. A statistically significant difference 
was considered for p<0.05.
Whole-body mouse X-Ray analysis
High-resolution X-ray (100 microns pixel size) 
analysis was performed using a Senograph Essential 
apparatus (GE Healthcare).
Histological analysis
For whole body histology, animals of 9-18 hours 
of life were killed with isoflurane, then fixed in a mix of 
ethanol-acetic acid-formol for 2 days, transfered in 70% 
ethanol and paraffin-embedded. Serial sagittal 10 µm 
sections were stained with HES. Pictures were taken using 
a Philips Image Management System 2.1 RA device. 
For brainstem histology and in situ hybridization, 
embryos were harvested and brains were fixed by 
immersion in 4% paraformaldehyde overnight at 4°C. 
Brains were washed in PBS then in PBS-15% sucrose 
before inclusion in PBS-10% gelatin-15% sucrose and 
freezed at -20°C. Twenty µm slides were cut with a 
cryostat at -20°C then stored or stained. Images were 
taken using the Philips device. In situ hybridization was 
performed as previously described [30] with an Alk probe 
corresponding to positions 523 to 1356 of the Alk cDNA 
NM_007432.2. The Alk riboprobe was synthesized using 
the DIG RNA Labeling Kit (Roche) as specified by the 
manufacturer.
Breathing analysis of newborn mice
Breathing variables were measured noninvasively 
using a battery of four whole-body flow barometric 
plethysmographs as previously described [31–
33]. Plethysmograph chambers were immersed 
in a thermoregulated water-bath that maintained 
their temperature at 33°C, which corresponds to 
thermoneutrality in newborn rodents. The pups were taken 
randomly from the litter and underwent a hypercapnic and 
a hypoxic test separated by a normoxic period. After 12-
min normoxia, hypercapnia was achieved by switching 
the airflow through the plethysmograph to 8% CO2 + 
21% O2 + 71% N2 at the same flow rate (200 ml/min per 
chamber) for 5 min, after which the flow was switched 
back to normoxia for 12 min. Then hypoxia was achieved 
by switching the airflow through the plethysmograph to 
10% O2 + 90% N2 at the same flow rate (200 ml/min per 
chamber) for 3 min, after which the flow was switched 
back to normoxia for another 12 min (total duration of the 
session: 44 min). Breath duration (T
TOT
, s), tidal volume 
(VT, µl/g), and minute ventilation (VE, calculated as VT/
T
TOT
, µl/s/g) were calculated on apnea-free periods. The 
baseline (i.e. normoxia condition) levels for T
TOT, 
VT 
and VE were calculated as the mean value averaged on 
breath-by-breath values over the 10-min of air-breathing 
preceding the hypercapnic exposure. Apneas were defined 
as ventilatory pauses longer than 0.9 s, and determined 
using an automatic classification method adapted from 
Matrot et al [32]. Total apnea duration was calculated over 
successive 30-sec periods. Activity was detected based on 
large disturbances in the respiratory signal caused by the 
combined effects of positional changes inside the chamber 
and changes in breathing pattern [32]. Total movement 
duration was calculated over successive 30-sec periods.
Statistical analysis
Statistical analyses were conducted using R (http://
www.R-project.org).
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